News About: Pharm. Industry
International trade in deficit despite export increase.
The pharmaceutical export in 2002 increased by 10.5% from the previous year while the import more by 53.8% up, showing a deficit balance in the international trade.
The total export in 2002 was amounted to U...
Domestic simvastatin market getting heated
With the incessant launchings of patent-expired simvastatin preparations, lipid-lowering agent, fierce competitions between domestic and foreign-invested pharmaceutical firms are being flared up.
Informed sources ...
Il Yang to sell a non-medicated anti-hypertension device.Il Yang made a contract with InterCure Co. for the distribution of RESPeRate, a medical device for the anti-hypertension, first in Asia.
RESPeRATE was approved by the U. S. F...
|
Viagra challengers will reach the domestic market
Business sources say that the domestic anti-impotence drugs market, which has been predominated by Pfizer's Viagra, will emerge as an arena of fierce competition among four pharmaceutical firms, Eli Liily' Cialis (tad...
Major domestic pharmaceutical firms eye 18.7% growth in turnover
The 23 major domestic pharmaceutical firms set their turnover growth rate this year at 18.7 percent on average (combined turnover: 4.1 trillion won) compared with 3.5 trillion won (estimated), according to the analyse...
Domestic pharmaceutical firms bent upon exploring overseas markets
Pharmaceutical business sources say that the leading Korean pharmaceutical firms have been endeavoring to further explore overseas markets in a bid to avert the cut-throat competition in the domestic pharmaceutical ma...
Acetylsalicylic acid included in the WHO Model List of Essential Drugs
Bayer Korea said on February 5 that acetylsalicylic acid (ASA), the active ingredient of Aspirin has been included by the World Health Organization (WHO) in its "Model List of Essential Drugs" in three categories.
...
Medilux launching a monitoring device for tissue blood in KoreaMediLux, one of Hanmi Pharm's subsidiaries, said on January 23 that it launched QFlow-500, a commercially available device that monitors human tissue blood flow in a continuous ...
|
Expansion of plant facility eyed, Janssen Korea says
Although many foreign-invested pharmaceutical firms are in the process of withdrawing their plants from Korea, Janssen Korea is scheduled to expand its plant at Hwasung of Kyunggi Province in the first half of this ye...
Pharmaceutical firms turn away quasi-drugs
Pharmaceutical business sources say that more clear definition on quasi-drugs, swifted from some OTCs whose safety and efficacy was already established, should be required to promote the sagging production of pharmace...
